Mark Gordon on Clubhouse
Bio
Predicting clinical trial outcomes so investments go to the most promising new medicines.
Founder/CEO, Diviner
Passionate about improving human health and wellbeing. And about mindfulness and meditation.
Diviner is a human intelligence startup for prioritizing investment in the most promising biotech and pharma new therapies. We forecast clinical trial outcomes to power investment strategies for biotech public and private equity funds. We are raising the second part of our seed round, to accelerate an ongoing proof of concept to forecast the results of 30 small-cap biotech clinical trials, assess the market’s view of them, and test an investment strategy based on the arbitrage.
Do you have drug development experience? Join our forecaster network and share in our upside: diviner.co
http://linkedin.com/in/markgordon
Invited by: Jason Kralic
Last 10 Records
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| December 03, 2023 | 78 | +2 | +2.7% |
| June 17, 2022 | 76 | -1 | -1.3% |
| December 28, 2021 | 77 | +1 | +1.4% |
| October 12, 2021 | 76 | +1 | +1.4% |
| September 03, 2021 | 75 | +29 | +63.1% |
